Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report

We report a 69-years-old Iranian HIV negative male patient, with long-standing pulmonary tuberculosis (eleven years) co-infected with non-tuberculosis mycobacteria. Despite of initiation of first line anti-tuberculosis therapy after diagnosis the patient poorly respond because of low compliance with...

Full description

Bibliographic Details
Main Authors:	Nafiseh Izadi, Mohammad derakhshan, Amin Samiei, Kiarash Ghazvini
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	Respiratory Medicine Case Reports
Subjects:	NTM XDR-TB Mycobacterium tuberculosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213007114000549

Similar Items

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
by: Ketaki V Utpat, et al.
Published: (2023-01-01)

Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
by: Mahdieh Sayadi, et al.
Published: (2020-06-01)

Tuberculosis extremadamente resistente (TB-XDR), historia y situación actual
by: Alberto Mendoza Ticona, et al.
Published: (2018-06-01)

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
by: Heidary M, et al.
Published: (2019-11-01)

Investigation of Susceptibility of Mycobacterium tuberculosis Complex Strains Isolated from Clinical Samples Against the First and Second-Line Anti-tuberculosis Drugs by the Sensititre MycoTB Plate Method
by: Figen KAYSERİLİ ORHAN, et al.
Published: (2018-03-01)

Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of <i>Mycobacterium tuberculosis</i>
by: María Alejandrina Martínez-González, et al.
Published: (2021-12-01)

Whole genome sequencing-based characterization of extensively drug resistant (XDR) strains of Mycobacterium tuberculosis from Pakistan
by: Zahra Hasan, et al.
Published: (2015-01-01)

Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review
by: Varshney K, et al.
Published: (2021-12-01)

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution
by: Ximena Gonzalo, et al.
Published: (2020-08-01)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Transmission Electron Microscopy of XDR Mycobacterium tuberculosis Isolates Grown on High Dose of Oﬂoxacin
by: Mohammad Arjomandzadegan, et al.
Published: (2017-02-01)

Effect of tellurite on growth of extensively drug resistant (XDR) Mycobacterium tuberculosis and action on mycobacterial drug efflux pump
by: Saba Kabir, et al.
Published: (2023-05-01)

Phenotypic detection of multi-drug and extensively drug resistant Mycobacterium tuberculosis among tuberculosis patients in Kaduna State, North West Nigeria
by: Kasimu Mamuda, et al.
Published: (2024-02-01)

Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, Japan
by: Yoshiro Murase, et al.
Published: (2010-06-01)

Predominance of Beijing lineage among pre-extensively drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care center experience
by: Syed Beenish Rufai, et al.
Published: (2016-01-01)

Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
by: Xiaocui Wu, et al.
Published: (2019-11-01)

Machine Learning Predicts Accurately Mycobacterium tuberculosis Drug Resistance From Whole Genome Sequencing Data
by: Wouter Deelder, et al.
Published: (2019-09-01)

XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems
by: Monika Kozińska, et al.
Published: (2022-02-01)

Pre-XDR spinal tuberculosis and 360° approach in two surgical times: a case report
by: C. Montero-Silva, et al.
Published: (2023-01-01)

Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
by: Cong Yao, et al.
Published: (2021-08-01)

Spread of Extensively Drug-resistant Tuberculosis
by: Sofía Samper, et al.
Published: (2007-04-01)

Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases
by: Isaac Darko Otchere, et al.
Published: (2023-01-01)

Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing
by: Jun Chen, et al.
Published: (2017-04-01)

Extensively drug-resistant tuberculosis: a case report and literature review
by: João Alves de Araújo-Filho, et al.

Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022
by: Dong-Mei Wang, et al.
Published: (2023-10-01)

Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa
by: Alistair D. Calver, et al.
Published: (2010-02-01)

Thymoquinone (TQ) inhibits the replication of intracellular Mycobacterium tuberculosis in macrophages and modulates nitric oxide production
by: Hafij Al Mahmud, et al.
Published: (2017-05-01)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
by: Zhang P, et al.
Published: (2022-05-01)

Extensively drug resistant tuberculosis in Mali: a case report
by: Bassirou Diarra, et al.
Published: (2017-11-01)

In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis
by: Ada Marie Hoffmann, et al.
Published: (2022-05-01)

Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil
by: Tania Matsui, et al.
Published: (2020-05-01)

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
by: Barbara Eker, et al.
Published: (2008-11-01)

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen <i>Mycobacterium tuberculosis</i>
by: Giuseppe Mancuso, et al.
Published: (2023-09-01)

Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China
by: Jian J, et al.
Published: (2018-10-01)

Turning the tide against tuberculosis
by: Nesri Padayatchi, et al.
Published: (2017-03-01)

First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda
by: Jupiter Marina Kabahita, et al.
Published: (2022-05-01)

High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates
by: Kanwara Trisakul, et al.
Published: (2022-12-01)

Usefulness of the mycobacterium tuberculosis direct assay in early diagnosis of extrapulmonary TB
by: Zhang Hui-Zhang, et al.
Published: (2014-01-01)